Cargando…

SAT-LB031 Empagliflozin as an Add-On Medication to Subjects Uncontrolled on DPP4 Inhibitors and Metformin: Real World Data Supporting the Use of Empagliflozin as a Rational Second Add-On in Indian Type 2 Diabetic Patients

A huge burden of uncontrolled type 2 diabetes mellitus (T2D) prevails in the Indian settings with an estimated prevalence of patients with >7 % HbA1c at 63 %(1) and glycaemic control tends to decline over time with monotherapy(2). Newer guidelines supported the use of DPP4 inhibitors along with S...

Descripción completa

Detalles Bibliográficos
Autor principal:	MS, ANEESH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552308/ http://dx.doi.org/10.1210/js.2019-SAT-LB031

Ejemplares similares

SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis
por: Thomas, Mathew, et al.
Publicado: (2019)

MON-LB031 Higher Insulin Degrading Enzyme Levels in Subjects with Metabolic Syndrome
por: Sofer, Yael, et al.
Publicado: (2019)

ODP173 Control of Alpelisib-Induced Hyperglycemia With DPP4- Inhibitors as add on to Metformin and Insulin
por: Hee, Nicholas Ken Yoong, et al.
Publicado: (2022)

SAT031 The Effect Of Metformin On Increasing Glucose Metabolism And Secretion In The Distal Intestine
por: Ho Nam, Jung, et al.
Publicado: (2023)

MON-645 Association of Baseline Cardio-Metabolic Parameters on the Treatment Effects of Empagliflozin When Added to Metformin in Patients with T2D
por: Inzucchi, Silvio E, et al.
Publicado: (2020)

SUN-LB031 An Atypical Case of Diabetic Keto-Alkalosis with Severe Hypernatremic Hyperosmolarity in a Patient with Amphetamine Abuse
por: Saini, Khushpreet Kaur, et al.
Publicado: (2019)

Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

Effects of Evogliptin as Add on in Type 2 Diabetes (T2DM) Subjects Inadequately Controlled With Metformin and Glimepiride Combination
por: Guha, Shaibal
Publicado: (2021)

SAT-LB128 A Case of Metformin Associated Lactic Acidosis and the Importance of Medication Reconciliation in End-Stage Renal Disease
por: Tsai, Karen, et al.
Publicado: (2020)

SAT-LB030 Efficacy of Combined Therapy with Metformin and Sitagliptin in Patients with Type 2 Diabetes Who Did Not Reach Target Levels of Glycated Hemoglobin on Metformin Monotherapy
por: Klitsunova, Yuliia, et al.
Publicado: (2019)

SAT-LB110 Sulfonylurea-Induced Hypoglycemia: To Use Octreotide or Not
por: Romeu, Jose, et al.
Publicado: (2020)

SAT-LB027 Does Diabetes Education Influence Glycosylated Hemoglobin?
por: Bhargava, Pooja, et al.
Publicado: (2019)

SAT-LB127 Regulation of ENaC by Exosomal Lipids in the Diabetic Kidney
por: Tuna, Kubra M, et al.
Publicado: (2020)

SAT-LB118 Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
por: Arao, Kevin A, et al.
Publicado: (2020)

SAT-LB126 Metformin Attenuates Sodium Retention and Blood Pressure in Hypertensive Diabetic Mice by Reducing the Phosphorylation of Renal NCC and Its Association With the Actin Cytoskeleton
por: Gholam, Mohammed F, et al.
Publicado: (2020)

Initial Combination Empagliflozin and Linagliptin Improves Kidney Fibrotic Marker in Patients With Type 2 Diabetes: A Randomized Controlled Trial
por: Sathavarodom, Nattapol, et al.
Publicado: (2021)

SAT-LB124 Phosphatidylcholine Transfer Protein Interacts With PPARδ to Modulate Activity
por: Druzak, Samuel Adam, et al.
Publicado: (2020)

SAT-LB117 POEMS Syndrome: Rare Presentation of New Onset Diabetes Mellitus
por: Jamal, Issra
Publicado: (2020)

SUN-LB122 Sequential Testing to Assess Insulin Resistance in the Course of Participation in a Diabetes Prevention Program (DPP)
por: McPhaul, Michael John, et al.
Publicado: (2020)

RF16 | PSUN155 Empagliflozin and the risk of nephrolithiasis
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2022)

SAT-LB115 Metformin-Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes Mellitus: The Sydney Memory and Ageing Study
por: Samaras, Katherine, et al.
Publicado: (2020)

SAT-LB029 Patient Participation Is Determined by Referral Source in an Intensive Diabetes Management Program
por: Blase, Bryan, et al.
Publicado: (2019)

SAT-LB024 Imprecision in Biomarker Analysis: Major Hurdle to Detection and Reversal of Disorders of Aging?
por: Comite, Florence, et al.
Publicado: (2019)

SAT-LB116 Extreme Insulin Resistance: The Diagnostic Challenges When Cost Is a Limitation
por: Cavalcante Parr, Nadia Carenina Nunes, et al.
Publicado: (2020)

OR22-1 Liraglutide as Add-on to SGLT2 Inhibitors in Patients with Inadequately Controlled Type 2 Diabetes (LIRA-ADD2SGLT2i): A 26-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Blonde, Lawrence, et al.
Publicado: (2019)

SAT-LB033 Cryptolepine Action on Insulin Resistance in High-Glucose Diet-Fed Caenorhabditis Elegans
por: Young, Ryan, et al.
Publicado: (2019)

THU371 Empagliflozin Associated Pancreatitis: A Case Report
por: Poloju, Alekya, et al.
Publicado: (2023)

SAT-LB119 Diabetic Ketoacidosis With PUMP Failure: Analysis of the 2006-2016 U.S. Kid Inpatient Database
por: Everett, Estelle, et al.
Publicado: (2020)

ODP192 Empagliflozin associated Euglycemic Diabetic Ketoacidosis and the Terrible Triad
por: Nievera, Karl Homer, et al.
Publicado: (2022)

SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
por: Oprea, Mihaela, et al.
Publicado: (2019)

SAT-LB111 Improving Classification of Diabetes Etiology in Electronic Resources Using Phenotype Algorithms and Polygenic Risk Scores
por: Sulieman, Lina, et al.
Publicado: (2020)

SAT-LB120 A Software Application Delivering Behavioral Therapy Improved Glycemic Control in Adults With Type 2 Diabetes
por: Guthrie, Nicole L, et al.
Publicado: (2020)

SAT-LB114 Metabolic Profile Changes in Patients With Diabetes Mellitus After Hurricane Maria: A Retrospective Case Series
por: Burgos, Nydia, et al.
Publicado: (2020)

SAT-148 Vitamin B12 Deficiency Among Patients with Metformin and Diabetic Neuropathy.
por: Alvarez, Mauricio, et al.
Publicado: (2019)

SAT-LB109 Implementation of a Quality Improvement Initiative for Advanced Ketone Management in Children With Recently Diagnosed Type 1 Diabetes
por: Jindal, Ishita, et al.
Publicado: (2020)

SUN-155 Clinical Experience of SGLT2 Inhibitors in a Hispanic Population: Should We Consider Its Use as Add-On Treatment?
por: Zayas, Francisco, et al.
Publicado: (2019)

SAT-LB026 Basal-Prandial Insulin versus Basal-Sliding-Scale Insulin in the Management of Hyperglycemia in Non-Critically Ill Hospitalized Patients
por: Malkhasyan, Victoria, et al.
Publicado: (2019)

SAT-LB122 Characterization and Functional Rescue of a Nephrogenic Diabetes Insipidus Causing S127F Substitution in V2 Vasopressin Receptor
por: Hunyady, Laszlo
Publicado: (2020)

PSUN250 Empagliflozin Induced Bladder Cancer in an Adult Patient With Latent Autoimmune Diabetes
por: Alzenaidi, Ahlam, et al.
Publicado: (2022)

SAT-LB032 Young Adult LEW.1WR1 Rats Develop Increased Glucose Intolerance on a Moderately Increased Sucrose Diet
por: Collins, Genoah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o9fapqf42r196um1dl926hi1du